Deals
Explore the dynamic landscape of pharma deals, mergers, acquisitions, and partnerships. Stay informed about strategic collaborations, licensing agreements, and investments shaping the industry. Get insights into the business side of pharmaceuticals and discover the key players driving innovation and growth.
Sanofi invests $10M in Proteome Sciences to access its protein map for drug discovery
Sanofi has taken a significant step toward its goal of becoming the first pharmaceutical company to harness the power of ...
GSK and Zhifei team up to distribute Shingrix in China and explore potential collaboration for RSV vaccine
GlaxoSmithKline has entered into a strategic partnership with Chongqing Zhifei Biological Products to distribute its shingles vaccine, Shingrix, in China. ...
QHP acquires Applied StemCell to strengthen its cell and gene therapy services for pharma clients
QHP Capital is expanding its portfolio of contract service providers by acquiring Applied StemCell (ASC), a specialized company in cell ...
Bristol Myers Squibb acquires Mirati Therapeutics in a $5.8 billion deal to expand its cancer treatment portfolio
Mirati Therapeutics, long speculated to be a potential acquisition target in the world of Big Pharma, has now sealed a ...
Amgen Successfully Completes $27.8B Acquisition of Horizon After FTC Dispute Resolution
Amgen has successfully concluded its monumental $27.8 billion acquisition of Horizon Therapeutics, triumphing over a legal challenge posed by the ...
BMS and Paradigm partner to bring clinical trials to community health providers
Bristol Myers Squibb (BMS) has embarked on a transformative collaboration with Paradigm, a groundbreaking startup focused on reimagining the clinical ...
Medable and Pluto Health partner to improve clinical trial recruitment
Medable, a trial software company, is teaming up with Pluto Health, a health data provider, to streamline and expedite patient ...
Kyowa Kirin to buy Orchard Therapeutics for $387M, expanding gene therapy portfolio
Kyowa Kirin has responded to the need to strengthen its late-phase pipeline by finalizing a deal to acquire Orchard Therapeutics ...
AbbVie acquires mitochondria biotech to boost Parkinsonās research
AbbVie has made a significant move in the field of Parkinson’s disease by acquiring Mitokinin for an upfront payment of ...
EQRxās ambitious plan to sell cheap drugs falls apart after $4.2B deal
EQRx, a biotech company founded with the ambitious mission of developing affordable medicines, recently found itself embroiled in a complex ...
Lilly Makes a Splash in Radiopharmaceuticals with $1.4B Acquisition of Point Biopharma
Eli Lilly is making a significant foray into the radiopharmaceutical cancer therapeutic sector with its acquisition of Point Biopharma Global ...
Sanofi Joins Forces with Teva, Merck, and Roivant in $500M Deal for Bowel Disease Race
Sanofi is making significant financial moves in the pharmaceutical landscape. Just one day after sealing a $175 million vaccine deal, ...
Sanofi Invests $175M in J&J’s Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts
Sanofi is making a strategic move by investing $175 million in Johnson & Johnson’s late-phase E. coli vaccine, ExPEC9V. As ...
Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval
Fresh from securing FDA approval for its combination treatment targeting Pompe disease, Amicus Therapeutics has attracted a significant investment. Amicus ...
Zeiss and Boehringer Ingelheim Collaborate on AI Initiative to Detect and Address Eye Diseases Earlier
A groundbreaking collaboration between Zeiss Medical Technology and Boehringer Ingelheim is set to revolutionise the early detection and treatment of ...
Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion
In a significant development nearly a year after Medtronic’s announcement of its intention to spin off its patient monitoring and ...
Merck KGaA expands AI partnership with Quris to predict drug toxicity
Merck KGaA continues to embrace the realm of artificial intelligence (AI), with a fresh development in its collaboration with Quris-AI. ...
Bluebird partners with Lonza to increase production of its gene therapies for rare diseases
As bluebird bio takes flight with its high-priced gene therapies, the company is enhancing its manufacturing capabilities through a strategic ...
Clario and CellCarta join forces to improve tissue and sample management in clinical trials
Clinical trial technology firm Clario has embarked on a strategic partnership with CellCarta to revolutionize the management of tissue and ...
Pfizer Collaborates with Ginkgo in a $331 Million Biobucks Partnership
Ginkgo Bioworks has secured a substantial partnership with pharmaceutical giant Pfizer, marking a significant milestone in its portfolio of collaborations. ...
AbbVie drops Caribouās CRISPR-edited CAR-T therapies after failed trials
AbbVie has chosen to end its partnership with Caribou Biosciences, signaling a significant shift in its strategic focus. This decision ...
Roche and Ionis expand partnership with new RNA programs for Alzheimerās and Huntingtonās
Roche, in its quest to find effective treatments for Alzheimer’s diseases after the setbacks of gantenerumab, has reaffirmed its commitment ...
Intercept Pharmaceuticals, After 2 FDA Setbacks and Restructuring Efforts, Finds a Buyer in Italy’s Alfasigma
Intercept Pharmaceuticals has faced substantial challenges over the past three years, particularly after the FDA rejected its attempts to bring ...
UK signs deal with CSL Seqirus for UK-made pandemic flu vaccines
The most recent flu pandemic occurred in 2009, generating significant anticipation but ultimately causing relatively low impact. However, the level ...
Takeda licenses AcuraStemās antisense drug for ALS targeting PIKFYVE
As scientific research continues to underscore the potential of targeting the PIKFYVE enzyme in the quest to combat amyotrophic lateral ...
AbbVie Withdraws from CD47 Arena, Ending Partnership with I-Mab
AbbVie has officially distanced itself from I-Mab, withdrawing from a once-promising collaboration focused on the anti-CD47 antibody lemzoparlimab, leaving I-Mab ...
Bayer and Hologic partner to promote contrast-enhanced mammography for breast cancer diagnosis
Bayer and Hologic have joined forces with the aim of providing enhanced breast cancer scans by combining Bayer’s imaging contrast ...
Glenmark sells API business to Nirma for $681M, wipes out debt
Glenmark Pharmaceuticals has successfully resolved its long-standing debt issue by divesting 75% of its active pharmaceutical ingredient (API) business. The ...
Abpro to go public via SPAC merger with Atlantic Coastal, raising funds for its HER2xCD3 bispecific and COVID-19 program
Abpro is making a return to the public market after a five-year hiatus, this time teaming up with Atlantic Coastal ...
COVID variants share common strategy to evade immune system, study finds
The spotlight on SARS-CoV-2, the virus responsible for COVID-19, has primarily focused on its spike protein, crucial for cell entry. ...
